)
)
Provention Bio Inc Investor Relations Material
Latest events
FDA Announcement
Provention Bio Inc
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Provention Bio Inc
Access all reports
Provention Bio Inc. is a biopharmaceutical company focused on the development of therapies aimed at preventing and intercepting immune-mediated diseases, particularly in areas with significant unmet medical needs. The company specializes in immunology, working to create treatments that modulate the immune system to prevent the onset or progression of chronic diseases. Provention Bio collaborates with healthcare providers and research institutions to bring innovative therapeutic options to patients at risk of developing conditions with autoimmune components. The company is headquartered in Red Bank, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PRVB
Country
🇺🇸 United States